215 related articles for article (PubMed ID: 28060219)
1. Multicenter Study of Adverse Events After Intravenous Tissue-Type Plasminogen Activator Treatment of Acute Ischemic Stroke.
Fernandez-Gotico H; Lightfoot T; Meighan M
J Neurosci Nurs; 2017 Feb; 49(1):31-36. PubMed ID: 28060219
[TBL] [Abstract][Full Text] [Related]
2. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.
Lewandowski CA; Frankel M; Tomsick TA; Broderick J; Frey J; Clark W; Starkman S; Grotta J; Spilker J; Khoury J; Brott T
Stroke; 1999 Dec; 30(12):2598-605. PubMed ID: 10582984
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
[TBL] [Abstract][Full Text] [Related]
4. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
5. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.
Shi ZS; Loh Y; Walker G; Duckwiler GR;
Stroke; 2010 Jun; 41(6):1185-92. PubMed ID: 20431084
[TBL] [Abstract][Full Text] [Related]
6. Aortic transgraft hemorrhage after intravenous tissue plasminogen activator therapy in patients with acute ischemic stroke.
Kawano T; Kajimoto K; Higashi M; Minatoya K; Toyoda K; Nagatsuka K
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2145-2150. PubMed ID: 25088170
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
9. Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA).
Marsh EB; Gottesman RF; Hillis AE; Urrutia VC; Llinas RH
Medicine (Baltimore); 2013 Nov; 92(6):317-323. PubMed ID: 24145699
[TBL] [Abstract][Full Text] [Related]
10. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
[TBL] [Abstract][Full Text] [Related]
11. Derivation and Validation of a Scoring System for Intravenous Tissue Plasminogen Activator Use in Asian Patients.
Yeo LLL; Chien SC; Lin JR; Liow CW; Lee JD; Peng TI; Luen TH; Sharma V; Chan B; Lee TH;
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1695-1703. PubMed ID: 28408066
[TBL] [Abstract][Full Text] [Related]
12. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update.
Katzan IL; Hammer MD; Furlan AJ; Hixson ED; Nadzam DM;
Stroke; 2003 Mar; 34(3):799-800. PubMed ID: 12624312
[TBL] [Abstract][Full Text] [Related]
13. Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid endarterectomy.
Vellimana AK; Yarbrough CK; Blackburn S; Strom RG; Pilgram TK; Lee JM; Grubb RL; Rich KM; Chicoine MR; Dacey RG; Derdeyn CP; Zipfel GJ
Neurosurgery; 2014 Mar; 74(3):254-61. PubMed ID: 24335814
[TBL] [Abstract][Full Text] [Related]
14. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
15. Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.
Lee VH; Conners JJ; Cutting S; Song SY; Bernstein RA; Prabhakaran S
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2139-2144. PubMed ID: 25081309
[TBL] [Abstract][Full Text] [Related]
16. Utility of early post-treatment single-photon emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator.
Abumiya T; Katoh M; Moriwaki T; Yoshino M; Aoki T; Imamura H; Aida T; Scichinohe H; Nakayama N; Kazumata K; Houkin K
J Stroke Cerebrovasc Dis; 2014; 23(5):896-901. PubMed ID: 24045082
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
[TBL] [Abstract][Full Text] [Related]
18. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
19. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
20. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
